Today: 23 May 2026
Rigetti Computing Stock Faces May 11 Earnings Test as RGTI Quantum Rally Cools

Rigetti Computing Stock Faces May 11 Earnings Test as RGTI Quantum Rally Cools

BERKELEY, California, May 3, 2026, 09:33 PDT

  • Rigetti Computing ended the session at $17.50, a 0.29% gain, before U.S. markets paused for the weekend.
  • First-quarter 2026 results from the company are scheduled for release after the market shuts on May 11.
  • Investors want to see if Rigetti’s 108-qubit debut and recent system orders actually translate to more predictable revenue.

Rigetti Computing Inc. faces its May 11 earnings with Wall Street watching for just one thing: will signs of real revenue finally back up the quantum pitch propping up RGTI stock after a rocky spring?

Timing is key here. This first-quarter report marks Rigetti’s debut earnings release after launching its 108-qubit Cepheus-1-108Q platform—now accessible via Rigetti’s own cloud and Amazon Braket. In quantum computing, a qubit represents the smallest unit of data; higher qubit counts open the door to tougher computational challenges, but stacking qubits doesn’t automatically deliver commercial results.

Expectations for Rigetti remain restrained. Zacks’ consensus, as highlighted in a recent Rigetti vs. D-Wave Quantum comparison, puts Rigetti’s Q1 loss at 5 cents per share on $3.3 million in revenue. That same analysis flagged a choppy near-term setup for both companies, citing “execution risks, timing uncertainties and volatile revenue recognition warrant caution.” TradingView

Rigetti shares closed at $17.50, giving the company a market cap close to $5.69 billion. Trading during the most recent session swung between $16.82 and $17.63, and roughly 16.6 million shares changed hands.

Here’s the sticking point: valuation isn’t lining up with reported revenue. Rigetti put up $7.1 million in revenue for 2025, posting a GAAP net loss of $216.2 million. Year-end numbers show $589.8 million in cash, cash equivalents, and available-for-sale investments.

The company touts a chiplet approach, aiming to scale quantum machines with smaller, connected modules instead of building out a single massive chip. According to Rigetti, Cepheus-1-108Q features 12 separate 9-qubit chiplets wired together, delivers a median two-qubit gate fidelity of 99.1% and a median single-qubit gate fidelity of 99.9%. Gate fidelity refers to how accurately quantum operations are performed.

Subodh Kulkarni, the company’s chief executive, described the 108-qubit rollout as “a milestone.” Eric Kessler, who runs Amazon Braket, pointed to the system offering customers “another choice” for quantum research. Those are strong signals, but investors are waiting for concrete figures, not just breakthroughs in the lab. Rigetti & Co, LLC

Rigetti is looking to extend its timeline beyond the U.S. borders. Back in March, the company announced plans to pour as much as $100 million into the UK and roll out a system topping 1,000 qubits within three to four years—marking its first significant international investment.

Market voices have turned more cautious lately. On May 2, Simply Wall St flagged proof of commercial demand for Rigetti’s updated systems as a key short-term driver. The firm still faces choppy revenue from government contracts and heavy cash outflows, according to the analysis.

The risks are hard to ignore. According to Rigetti’s annual filing, much of its revenue relies on government contracts, and scaling up quantum computers remains a major technical hurdle. Missed orders, slower funding, or another shift in the technology road map—all could put the valuation question back on the table by the next earnings call.

At this point, the May 11 report isn’t really weighing the future of quantum computing itself. Instead, it’s all about Rigetti: can it actually deliver right now? Investors want to see recognized revenue, shipped systems, tighter cash management, and a road map that moves past wishful thinking to something that feels like actual execution.

Stock Market Today

  • Santen Pharmaceutical Raises Dividends and Issues 2027 Earnings Guidance Amid Market Reaction
    May 23, 2026, 2:04 PM EDT. On 12 May 2026, Santen Pharmaceutical (TSE:4536) raised its interim and year-end dividends to ¥21.00 per share for fiscal year ending March 2027, confirming a ¥19.00 dividend for FY 2026. The company issued FY2027 guidance projecting revenue of ¥311 billion, operating profit of ¥49.5 billion, and net profit of ¥39.5 billion. The dividend hike underscores confidence in earnings and shareholder returns but raises concerns about reliance on meeting guidance amid modest revenue growth. Shares gained but remain potentially undervalued by 43%, with market views split between optimism over dividends and caution on growth forecasts. Investors are advised to weigh the trade-offs and consider fundamental analysis before deciding.

Latest articles

Intuit Just Cut 3,000 Jobs. The Real Test Is Whether TurboTax Can Outrun AI

Intuit Just Cut 3,000 Jobs. The Real Test Is Whether TurboTax Can Outrun AI

23 May 2026
Intuit will cut about 3,000 jobs, or 17% of its workforce, and close offices in Reno and Woodland Hills as it restructures to focus on artificial intelligence. The company expects $300 million to $340 million in charges, mostly in the fiscal fourth quarter. Intuit raised full-year revenue guidance but lowered its TurboTax outlook, citing pressure from low-cost AI tools. Shares last traded at $319.94 after a volatile week.
AeroVironment Stock Watch: Navy Laser Test Puts AVAV Back in Drone-Defense Focus

AeroVironment Shares Surge 10% Ahead of Holiday With Tuesday in Focus for AVAV

23 May 2026
AeroVironment shares jumped 6.8% Friday to $174.23, capping a 10.3% weekly gain ahead of the Memorial Day market closure. Trading volume reached 1.16 million shares. No new company news appeared Friday; the latest updates were a May 19 software announcement and a May 20 notice of management’s June 3 conference appearance. Peers rose less, with Kratos up 2.8% and Lockheed Martin up 2.0%.
Lockheed Martin Rises Going Into Holiday on Missile Plans

Lockheed Martin Rises Going Into Holiday on Missile Plans

23 May 2026
Lockheed Martin shares rose 2.0% to $533.24 on Friday, outpacing defense peers after the company broke ground on a new munitions plant in Troy, Alabama. The facility aims to boost output of THAAD and Next Generation Interceptor missiles. Lockheed remains nearly 23% below its 52-week high despite recent gains. Wall Street analysts hold a consensus Hold rating with an average price target of $595.29.
Constellation Energy Stock: AI Power Demand Faces a Crucial May Test After Shareholder Vote
Previous Story

Constellation Energy Stock: AI Power Demand Faces a Crucial May Test After Shareholder Vote

Delta Flight Cancellations Top 400 As Crew Strain Puts Summer Travel At Risk
Next Story

Delta Flight Cancellations Top 400 As Crew Strain Puts Summer Travel At Risk

Go toTop